UPDATED Apr 17, 2024
Less coverage brings about more information asymmetry and more opportunities to buy mispriced stocks. Companies valued at less than US$500M with low PE and PEG.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FAR | CA$3.20 | 0.3% | 66.7% | CA$312.1m | CA$5.13 | PE8x | E26.7% | 1.9% | Materials | ||
THX | CA$0.24 | 0% | -27.3% | CA$163.8m | n/a | PE5.1x | E25.1% | n/a | Materials | ||
INCR.U | ₪1.53 | -7.8% | -73.7% | ₪260.4m | n/a | PE8.2x | E46.6% | n/a | Pharmaceuticals & Biotech | ||
SBI | UK£1.24 | 13.8% | 138.5% | UK£50.7m | UK£1.85 | PE13.4x | E36.2% | n/a | Materials | ||
MDP | CA$1.51 | -3.2% | 2.0% | CA$37.7m | CA$3.21 | PE4.5x | E46.9% | n/a | Pharmaceuticals & Biotech | ||
TCF | CA$0.17 | 0% | -91.2% | CA$19.7m | n/a | PE2.6x | E59.6% | n/a | Energy |